Connect with us
Stanbic IBTC
Fidelity ads

Market Views

Pfizer’s COVID-19 vaccines expected to generate $15 billion in 2021

Stock experts had earlier anticipated that Pfizer would earn $12.7 billion from its COVID-19 vaccines sales in 2021.



The world’s leading drug maker, Pfizer, has issued a mixed earnings report on its fourth quarter of the 2020 fiscal year that slightly missed stock experts’ prediction.

However, investors were surprisingly upbeat on Pfizer’s sales prediction from its COVID-19 vaccines in 2021, as the company disclosed that it expected the vaccines to generate around $15 billion in 2021. Stock experts had earlier anticipated that it would earn $12.7 billion in 2021.

Pfizer’s most recent result revealed that the fourth-quarter adjusted diluted earnings per share of 42 cents, below the 50 cents analysts expected.

READ: Covid-19: Less than 20,000 vaccines administered in Africa so far – UN

Revenues for the fourth quarter were $11.7 billion, just above the FactSet consensus of $11.5 billion.

Frank D’Amelio, Chief Financial Officer and Executive Vice President, Global Supply, stated:

  • “I am very pleased with how our company performed in 2020, and particularly in the fourth quarter, where we achieved double-digit operational revenue growth driven by a wide range of products and geographies, including growth within all of our therapeutic areas.
  • “I was also pleased that Pfizer completed the transaction to combine Upjohn with Mylan to form Viatris in the fourth quarter, which I believe positions both Pfizer and Viatris for a bright future.
  • “I feel confident in our ability to continue to perform well and deliver on our commitments in 2021 and beyond, both to our patients and to our shareholders.
  • “The company is working round the clock in order to deliver two billion doses of the vaccine this year alone at a breakneck pace as nations rush to sign supply deals in an effort to control the worst pandemic seen in humanity taking to account it had killed over 2 million people globally.”

READ: COVID-19: Pfizer’s vaccine shipments begin in the US

Edward Jones analyst, Ashtyn Evans, told Reuters, “2021 earnings and sales will see a significant benefit from the vaccine, and this benefit could increase throughout the year.”

Pfizer also revealed it had supplied 65 million doses worldwide and 29 million doses in the world’s largest economy, the US, as of Jan. 31. It expects to supply 200 million doses to the U.S. government by the end of May.

Its biggest contracts so far have charged countries around $19 per dose. Pfizer and BioNTech split the gross profit from the vaccine by half under their partnership agreement.

At the time of writing this report, Pfizer shares were down 2.63%, trading at $34.86 at the New York Stock exchange, as investors, pulled back some of their long positions.

Olumide Adesina is a France-born Nigerian. He is a Certified Investment Trader, with more than 15 years of working expertise in Investment trading. Follow Olumide on Twitter @tokunboadesina. He is a Member of the Chartered Financial Analyst Society.

Click to comment

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Market Views

Bears take Nigerian stocks hostage, investors lose N82.4 billion

Investor sentiment as measured by the market breadth closed negative with 12 advancers and 47 decliners.




Nigeria’s all-share index fell further at the close of trading today, down by -0.40% to 39,364.67 points. Investors losses today stood at N82.35 billion.

  • Year-to-date return and market capitalization settled at -2.26% and N20.5 trillion, respectively.
  • Investor sentiment as measured by the market breadth closed negative with 12 advancers and 47 decliners.
  • Across coverage sectors, the performance was bearish. The NSE insurance, banking, consumer goods, and oil & gas sectors dipped 4.04%, 1.54%, 1.47%, 64 basis points, and 0.65%, respectively.
  • The flip side saw only the industrials improved marginally by 0.19%.

Top gainers

  1. UPL up 9.91% to close at N1.22
  2. MORISON up 9.09% to close at N0.6
  3. CAP up 5.26% to close at N20
  4. WAPCO up 3.59% to close at N20.2
  5. LIVESTOCK up 3.17% to close at N2.28

Top losers

  1. FIDSON down 10.00% to close at N4.41
  2. NNFM down 9.97% to close at N6.32
  3. ENAMELWA down 9.95% to close at N19.9
  4. NEM down 9.95% to close at N1.72
  5. NCR down 9.91% to close at N3.09


Nigerian stocks ended the fourth trading session on a weaker note amid soaring oil prices prevailing at the U.S trading session.

  • Today’s bearish trading session was inclined by sell pressure on consumer ticker, DANGSUGAR which lost -6.25%. JBERGER, ARDOVA, and UBA also declined by -7.88%, 9.85%, and -3.64%, respectively.
  • Nairametrics expects intending buyers to seek the advice of certified stockbrokers.

Continue Reading

Market Views

Nigerian stocks plunge, as WEMA, CHAMPION, MANSARD slump

The market breadth closed negative as LASACO led 17 Gainers as against 23 Losers topped by CHAMPION at the end of today’s session.



Nigerian banking stocks remain most liquid stocks, as investors gain N25.1 billion, DANGOTE CEMENT, OKOMUOIL and GUINNESS drag Nigerian Stock market down,  SEPLAT, GUINNESS, Breaks Nigerian Bourse Support Levels, Investors Lose N49 Billion  

Nigerian stocks wrapped up the week on a bearish note after the benchmark index registered its third negative close in the last five sessions.

  • Sentiments notably picked up where they left off yesterday, as selloffs persisted in bellwether ticker – ZENITHBANK (-1.55%) as well as in Telco giant – MTN Nigeria (-3.28%).
  • The 74 basis points pullback recorded today kept the All Share Index return firmly rooted in the red and also lowering the Year date returns to -1.88%.
  • Save for the Oil and Gas (+0.25%) index lifted by sustained interest in OANDO (+2.99%), all other sectors closed in the negative territory.
  • The Insurance (-2.32%), Banking (-0.48%), Consumer Goods (-0.40%), and Industrial Goods (-0.19) indices declined following price dips in MANSARD (-5.36%), ZENITHBANK (-1.55%), INTBREW (-3.65%), and WAPCO (-2.94%) respectively.
  • The market breadth closed negative as LASACO led 17 Gainers as against 23 Losers topped by CHAMPION at the end of today’s session

Top gainers

  1. LASACO down 9.82% to close at N1.23
  2. MBENEFIT down 8.11% to close at N0.37
  3. COURTVILLE down 5.00% to close at N0.21
  4. OANDO down 2.99% to close at N3.45
  5. NAHCO down 2.70% to close at N2.28

Top losers

  1. WEMABANK down 10.00% to close at N0.63
  2. CHAMPION down 10.00% to close at N2.52
  3. SUNUASSUR down 9.59% to close at N0.66
  4. AFRIPRUD down 5.74% to close at N5.75
  5. MANSARD down 5.36% to close at N1.06


Nigerian stocks ended the last trading session of the week on a bearish note amid profit-taking across the market spectrum.

  • Downtrend was driven by price depreciation medium capitalized stocks amongst which are; WEMA, CHAMPION, MANSARD.
  • That being said, Nairametrics envisages cautious buying on the account that certain market indicators reveal investors are taking some of their gains across the market spectrum.

Continue Reading


Nairametrics | Company Earnings